These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 22301383)

  • 1. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model.
    Tsilingiri K; Barbosa T; Penna G; Caprioli F; Sonzogni A; Viale G; Rescigno M
    Gut; 2012 Jul; 61(7):1007-15. PubMed ID: 22301383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should probiotics be tested on ex vivo organ culture models?
    Tsilingiri K; Rescigno M
    Gut Microbes; 2012; 3(5):442-8. PubMed ID: 22713266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major advance in ex vivo intestinal organ culture.
    Wildenberg ME; van den Brink GR
    Gut; 2012 Jul; 61(7):961-2. PubMed ID: 22315470
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD.
    Pagnini C; Martorelli M; Lanini C; Delle Fave G
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S179-S182. PubMed ID: 27741170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
    Isolauri E; Salminen S;
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract.
    Daniluk U; Alifier M; Kaczmarski M
    Adv Med Sci; 2012; 57(2):175-82. PubMed ID: 22968339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Probiotics for inflammatory bowel disease].
    Iizuka H; Takaishi H; Hibi T
    Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in inflammatory bowel disease--therapeutic rationale and role.
    Shanahan F
    Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postbiotics: what else?
    Tsilingiri K; Rescigno M
    Benef Microbes; 2013 Mar; 4(1):101-7. PubMed ID: 23271068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease?
    Cary VA; Boullata J
    J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats.
    Sengül N; Aslím B; Uçar G; Yücel N; Işik S; Bozkurt H; Sakaoğullari Z; Atalay F
    Dis Colon Rectum; 2006 Feb; 49(2):250-8. PubMed ID: 16362802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microecology in chronic inflammatory bowel diseases.
    Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR
    Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.